Faruqi & Faruqi, LLP Announces Investigation of HealthSpring, Inc.

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE: HS) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Cigna Corporation (NYSE: CI) in an all-cash deal valued at about $3.8 billion. Under the terms of the proposed transaction, HealthSpring stockholders will receive $55 in cash for each share of HealthSpring common stock they own. According to Yahoo! Finance, at least one financial analyst has set a price target of $61 for HealthSpring.